Hemodialysis Patients Make Long-Lived Antibodies against SARS-CoV-2 that May Be Associated with Reduced Reinfection. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1681/asn.2021020188
PubMed Identifier: 34341181
Publication URI: http://europepmc.org/abstract/MED/34341181
Type: Journal Article/Review
Volume: 32
Parent Publication: Journal of the American Society of Nephrology : JASN
Issue: 9
ISSN: 1046-6673